Total buying$00 buys
GH
Guardant Health, Inc.
NasdaqHealthcareServices-Medical Laboratories
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$11.0k1 sells
Net open-market−$11.0kBuying minus selling
Active insiders10Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 15, 2026
Open-market transaction mix · 1 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Oct 2026 | 0 | 1 | 0 | $0 | $11.0k | -$11.0k |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (9)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- SG-$647.6k
- MJ-$366.6k
- AI-$11.0k
- KK+$0
GH transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
GHGuardant Health, Inc. | Azar Alex M IIDIR | S · saleSEC filing ↗ | -$11.0kView disclosure → | |
GHGuardant Health, Inc. | Azar Alex M IIDIR | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Azar Alex M IIDIR | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | F · withholdingSEC filing ↗ | -$647kView disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Saia John G.CLO | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Monroe Terilyn J.CPO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Monroe Terilyn J.CPO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Monroe Terilyn J.CPO | F · withholdingSEC filing ↗ | -$366kView disclosure → | |
GHGuardant Health, Inc. | Monroe Terilyn J.CPO | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Monroe Terilyn J.CPO | M · exerciseSEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Kalia KumudCIO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Kalia KumudCIO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
GHGuardant Health, Inc. | Kalia KumudCIO | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period69transactionstxns
- M · Option exercise · dominant58 · 84%
- F · Tax withholding10 · 14%
- S · Open-market sells1 · 1%
Activity by reported role
A joint filing can contribute to multiple rolesChief executive officer16
CCO9
CIO9
CLO9
CTO9
Chief financial officer7
CPO5
Director5
Reported Holdings After
Separated by insider, security, and ownership type
Eltoukhy HelmyCommon Stock · Indirect · Shares held by Helmy A. Eltoukhy Revocable Trust
1,958,949Oct 01, 2026
Talasaz AmirAliCommon Stock · Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
1,842,366Oct 01, 2026
Chudova DaryaCommon Stock · Direct
74,348Oct 01, 2026
Freeman ChrisCommon Stock · Direct
69,647Oct 01, 2026
Kalia KumudCommon Stock · Direct
42,773Oct 01, 2026
Saia John G.Common Stock · Direct
42,348Oct 01, 2026
Bell Michael BrianCommon Stock · Direct
55,182Oct 01, 2026
Chudova DaryaRestricted Stock Units · Direct
10,202Oct 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Guardant Health, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Guardant Health, Inc.?
Azar Alex M II, Saia John G., Monroe Terilyn J., Kalia Kumud, Freeman Chris, Chudova Darya, Bell Michael Brian, Talasaz AmirAli, Eltoukhy Helmy, MIGNONE ROBERTO.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Azar Alex M II reported a sale on Oct 14, 2026 valued at $11.0k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $11,032.41. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.